Disagree entirely. The spike was caused by some positions being taken following the changes to breast screening guidelines, followed by some FOMO buyers. That will always cause a spike in a stock like this.
There will be more positions taken in GTG before the scientific validation results are released QTR1 2016, so I would expect a few of these spikes over the next few months.
The current selling is the FOMO buyers crapping their pants. Good riddance.
possible run?, page-198
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
